Fundraising Fox
/Companies
Sign in

xMD Diagnostics

Annapolis, US · Maryland corporation · 2 known investors

Find your way into xMD Diagnostics

Sign up to see every warm intro you have to xMD Diagnostics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the xMD Diagnostics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

xMD Diagnostics develops laboratory instruments and consumables for molecular diagnostics, aimed at enriching samples for downstream molecular testing. It serves research, biopharmaceutical, and clinical (CLIA) laboratories to help pathologists, oncologists, and other physicians diagnose, monitor, and treat cancer and other genetic diseases.

BiotechHealthtechMedical Devices

Founders & leadership

BSBenjamin Shapiro
Benjamin ShapiroCo-Founder, Technical Advisor
AF
Al FleuryExecutive
TPTing Pau Oei
Ting Pau OeiCEO and Co-ChairmanTing Pau Oei spent 22 years at Johnson & Johnson, including 12 years as Vice President at its venture capital arm, and subsequently held investment roles at L Capital Partners and Easton Capital before co-founding xMD Diagnostics in 2015, where he serves as CEO and Co-Chairman. He founded Fox Feather Ventures LLC in 2012, a venture capital advisory firm focused on life science companies in biopharmaceuticals, medical devices, diagnostics, and digital health.
ME
Michael Emmert-BuckNamed on SEC filing
NMNicole Massoll, M.D.
Nicole Massoll, M.D.Medical Director, Pathologist

Board

SRStephen Ritterbush
Stephen RitterbushCFO and Co-Chairman

Investors · 2

TEDCOlisted by TEDCOColumbia

Reported raises · per SEC filings

Form D private placements

$675K disclosed across 2 rounds · 2017–2018

▶$500KraisedOct 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen R. RitterbushExecutive Officer, Director
  • Ting Pau OeiExecutive Officer, Director
  • Benjamin ShapiroExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$500K
First sale
Oct 2018
Incorporated
Corporation, Maryland
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$175KraisedMar 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Al FleuryExecutive Officer
  • Michael Emmert-BuckExecutive Officer
  • Ting Pau OeiExecutive Officer, Director
  • Benjamin ShapiroExecutive Officer, Director
  • Stephen RitterbushExecutive Officer, Director
Offering amount
$350K
Amount sold
$175K
Proceeds to insiders
$35K
First sale
Jan 2017
Incorporated
Limited Liability Company, Maryland
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

MDxHealthMDxHealth is a commercial-stage precision diagnostics company offering molecular diagnostic tests to guide the diagnosis and treatment of prostate cancer and other urologic diseases. Its tests use proprietary genetic, epigenetic, and molecular technologies and serve physicians, patients, payers, and providers.
AdvancedmdAdvancedMD provides cloud-based medical office software for ambulatory and independent medical practices, offering practice management, electronic health records, telemedicine, patient relationship management, and business analytics reporting. It also offers outsourced medical billing options and serves practitioners, practices, and billing companies across the United States.
CdxdiagnosticsCDx Diagnostics develops AI-powered diagnostic technology that detects precancerous cells in the gastrointestinal tract to enable early cancer prevention. The proprietary platform combines computer imaging, artificial intelligence, and molecular biology for healthcare providers.

Companies working in the same space as xMD Diagnostics.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase I2021$256K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does xMD Diagnostics do?
xMD Diagnostics develops laboratory instruments and consumables for molecular diagnostics, aimed at enriching samples for downstream molecular testing. It serves research, biopharmaceutical, and clinical (CLIA) laboratories to help pathologists, oncologists, and other physicians diagnose, monitor, and treat cancer and other genetic diseases.
Who founded xMD Diagnostics?
xMD Diagnostics was founded by Benjamin Shapiro.
Who are xMD Diagnostics's investors?
xMD Diagnostics's investors include Maryland TEDCO, TEDCO.
How much funding has xMD Diagnostics raised?
xMD Diagnostics has disclosed $675K raised across 2 rounds.
Where is xMD Diagnostics headquartered?
xMD Diagnostics is headquartered in Annapolis, US.